Intervention
atrial fibrillation
ATRIAL FIBRILLATION, TYPE 2 DIABETES
Participants were randomly assigned (1:1) to mirabegron (50 mg/d) or placebo, stratified by the presence of atrial fibrillation and/or type 2 diabetes, for 12 months.